Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Lefvert

Showing results (51-60 of 181) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Immunology|October 1, 1986
Periductal lymphocytic infiltrates in salivary glands in myasthenia gravis patients lacking Sjögren's syndromeG Lindahl, A K Lefvert, E Hedfors
Muscle & Nerve|September 1, 1978
Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravisE Heilbronn, A K Lefvert, E Stålberg
Journal of Neuroimmunology|February 1, 1993
Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravisQ Yi, R Pirskanen, A K Lefvert
Acta Neurologica Scandinavica|July 21, 1998
Treatment of myasthenia gravis with methylprednisolone pulse: a double blind studyC Lindberg, O Andersen, A K Lefvert
Journal of Neuroimmunology|March 1, 1981
Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravisA K Lefvert, S Cuénoud, B W Fulpius
Cell Biophysics|August 1, 1992
The clinical significance of HAMA in patients treated with mouse monoclonal antibodiesJ E Frödin, A K Lefvert, H Mellstedt
Clinical Immunology and Immunopathology|November 1, 1987
Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodiesA C Sundewall, A K Lefvert, R Norberg
Cancer Research|August 15, 1990
Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedulesJ E Frödin, A K Lefvert, H Mellstedt
Journal of Neuroimmunology|December 10, 1998
Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravisB Y Xu, R Pirskanen, A K Lefvert
Acta Neurologica Scandinavica|September 20, 2007
Treatment of a patient with myasthenia gravis using antibodies against CD25M Kakoulidou, R Pirskanen-Matell, A K Lefvert
Pageof 19

Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Immunology|October 1, 1986
Periductal lymphocytic infiltrates in salivary glands in myasthenia gravis patients lacking Sjögren's syndromeG Lindahl, A K Lefvert, E Hedfors
Muscle & Nerve|September 1, 1978
Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravisE Heilbronn, A K Lefvert, E Stålberg
Journal of Neuroimmunology|February 1, 1993
Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravisQ Yi, R Pirskanen, A K Lefvert
Acta Neurologica Scandinavica|July 21, 1998
Treatment of myasthenia gravis with methylprednisolone pulse: a double blind studyC Lindberg, O Andersen, A K Lefvert
Journal of Neuroimmunology|March 1, 1981
Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravisA K Lefvert, S Cuénoud, B W Fulpius
Cell Biophysics|August 1, 1992
The clinical significance of HAMA in patients treated with mouse monoclonal antibodiesJ E Frödin, A K Lefvert, H Mellstedt
Clinical Immunology and Immunopathology|November 1, 1987
Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodiesA C Sundewall, A K Lefvert, R Norberg
Cancer Research|August 15, 1990
Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedulesJ E Frödin, A K Lefvert, H Mellstedt
Journal of Neuroimmunology|December 10, 1998
Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravisB Y Xu, R Pirskanen, A K Lefvert
Acta Neurologica Scandinavica|September 20, 2007
Treatment of a patient with myasthenia gravis using antibodies against CD25M Kakoulidou, R Pirskanen-Matell, A K Lefvert
Pageof 19